Physician
Khera, Mohammad
Khera, Mohammad was paid $4.24M by Medicaid between Jan 2018 and May 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 46% of everything it billed.
33Billing provider infoKHERA, MOHAMMAD
WINSTED, CT 06098
WINSTED, CT 06098
33aNPI1073570784assigned 04/27/2006
33bProvider typePediatrics Physician
28Total paid$4.24M
24GClaims97,210
24DCodes billed47
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Pediatrics Physician providers in Connecticut
Rank by total paid#18 of 162
Median peer was paid$313K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,654 | $683K | |
| 2019 | 12,240 | $594K | |
| 2020 | 11,258 | $517K | |
| 2021 | 20,175 | $577K | |
| 2022 | 16,305 | $754K | |
| 2023 | 18,123 | $814K | |
| 2024incomplete | 6,455 | $302K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 46% | 26,155 | 17,883 | $1.93M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.0% | 3,945 | 2,912 | $381K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 2,113 | 1,724 | $220K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 1,980 | 1,592 | $213K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.9% | 1,797 | 1,516 | $206K |
| 96127 | 4.8% | 9,436 | 6,678 | $204K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 1,893 | 1,225 | $175K |
| 99050 | 2.9% | 9,224 | 7,006 | $123K | |
| 99174 | 2.7% | 7,254 | 6,019 | $115K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.6% | 5,647 | 4,443 | $112K |
| 92587 | 2.2% | 3,547 | 2,736 | $92K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.9% | 4,092 | 3,674 | $82K |
35 more codes
| 96160 | 1.2% | 2,917 | $53K | |
| 92558 | 1.2% | 2,470 | $51K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 488 | $49K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 1,015 | $46K |
| 96111 | <1% | 511 | $39K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,044 | $38K |
| 99188 | <1% | 1,780 | $33K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,174 | $20K |
| 99442 | <1% | 424 | $16K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,458 | $16K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 239 | $5K |
| D1206 | Topical application of fluoride varnish | <1% | 240 | $4K |
| 99401 | <1% | 109 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 177 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 267 | $3K |
| 92650 | <1% | 74 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 60 | $616.05 |
| 86580 | <1% | 18 | $81.38 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 60 | $64.71 |
| 90688 | <1% | 93 | $0.54 | |
| 90685 | <1% | 100 | $0.11 | |
| 90633 | <1% | 867 | $0.10 | |
| 90651 | <1% | 841 | $0.08 | |
| 90686 | <1% | 1,476 | $0.07 | |
| 90715 | <1% | 297 | $0.06 | |
| 90734 | <1% | 148 | $0.04 | |
| 90672 | <1% | 151 | $0.03 | |
| 90744 | <1% | 48 | $0.01 | |
| 90670 | 0% | 461 | $0.00 | |
| 90710 | 0% | 87 | $0.00 | |
| 90644 | 0% | 92 | $0.00 | |
| 90461 | 0% | 361 | $0.00 | |
| 90671 | 0% | 29 | $0.00 | |
| 90698 | 0% | 492 | $0.00 | |
| 90619 | 0% | 59 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.